- Report
- January 2026
- 134 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 288 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 382 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 235 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 178 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 183 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 289 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 375 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 250 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 227 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 422 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 320 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 221 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 326 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 224 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 181 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 290 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 285 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more